Nobel is a long-established pharmaceutical company operating internationally and representing the Turkish brand in a wide geography. With one hundred percent domestic capital and more than half a century of experience, Nobel has a respectable history.
Launch of the Düzce Special Products Facility.
1st Place in Pharmaceutical Exports on the ISO 500 Türkiye List Türkiye’s #1 Pharmaceutical Exporter (ISO 500).
İKMİB (İstanbul Chemicals and Chemical Products Exporters' Association) Pharmaceutical Exports Category – 2nd Place.
Production Partnership Between Nobel AFF and AstraZeneca in Kazakhstan.
The pharmaceutical industry’s first 360-degree communication campaign with "Çok 70 Olsun".
$40 million facility investment in Düzce for high-potency product manufacturing.
Nobel AFF received the "Best Investor" award for its contributions to the development of Kazakhstan's healthcare sector.
Nobel AFF signed a biotechnological drug production cooperation agreement with the Kazakhstan Ministry of Health Institution SK-Pharmacia LLP, the Kazakh Institute of Oncology and Radiology, and Swiss pharmaceutical company Roche.
Nobel AFF in Kazakhstan awarded the "Kurmet" (Honor) Medal.
Representation Office established in Tajikistan.
Establishment of Nobel L., UAB and its representation Office in Lithuania.
Awarded the "Certificate of Merit" by the Uzbekistan Agency for the Development of the Pharmaceutical Industry for being the company that contributed the most to public health protection and patient treatment during the pandemic.
Nobel Pharma Schweiz AG has launched 6 products along with neotylol.
Nobel Pharma Schweiz AG has been founded.
Nobel Pharmasanoat has obtained GMP Certificate of Uzbekistan new manufacturing plant.
Nobel Pharmaceuticals won the first prize in the category of “Export of Pharmaceutical Products” at the “İKMİB Stars of Export Awards” organized by Istanbul Chemicals and Chemical Products Exporters’ Association.
Nobel Pharmaceuticals has been the only pharmaceutical company to have received the “Best Managed Companies Turkey” award, which has been practiced abroad for 25 years and which has been implemented for the first time in Turkey this year by Deloitte Private.
Nobel Pharmaceuticals became the fastest growing pharmaceutical company of Belarus.
The state-of-the-heart “High Bay” warehouse became operative in the Düzce manufacturing facility.
Nobel Pharmaceuticals was awarded the second prize in the category of “Export of Pharmaceutical Products” at the “İKMİB Stars of Export Awards” organized by Istanbul Chemicals and Chemical Products Exporters’ Association.
IFC, a World Bank Group institution, provided credit support to the biotechnological drug manufacturing facility investment of Nobel Pharmaceuticals.
Nobel Pharmaceuticals in Albania was chosen as “The Best Pharmaceutical Company” by the Albanian Chamber of Commerce and Industry.
Nobel Pharmaceuticals was awarded the “International Corporate Social Responsibility 2016 Award” by Junior Chamber International (JCI) with the Voluntary Trainer Program carried out with TEGV.
Nobel Pharmaceuticals was awarded the third prize in the category of “Export of Pharmaceutical Products” at the “İKMİB Stars of Export Awards” organized by Istanbul Chemicals and Chemical Products Exporters’ Association
Nobel Pharmaceuticals has been the first company whose project was approved in the announcement of “Domestic development and manufacturing of biosimilar drugs” made by TÜBITAK within the scope of the support program of the Ministry of Health.
Nobel Pharmaceuticals was included in the brand support program (TURQUALITY) within the framework of the state-supported branding program.
The Nobel R&D center was registered by the Turkish Republic Ministry of Science, Industry and Technology.
Nobel AFF was honored with the “Order of Merit of Kazakhstan”.
Representation office of Nobel Pharmaceuticals was opened in Mongolia.
Nobel AFF has been the first Turkish pharmaceutical manufacturer to be granted a GMP certificate in Kazakhstan.
The investment on the manufacturing facilities of biotechnological and high potent products was initiated in Düzce.
Representation office of Nobel Pharmaceuticals was opened in Kosovo.
Export to Switzerland began for gastrointestinal system and urology products.
Tylol Hot becomes one of the most recognized/ well-known brands of Nobel.
Nobel launched Turkey’s first biosimilar erythropoietin product into market.
Representation offices of Nobel Pharmaceuticals were opened in Belarus, Macedonia.
Nobel was declared a “well-known brand” by the Turkish Patent Institute.
Nobelfarma and Ulkar Kimya were granted EU-GMP certificates.
Nobel is the export leader of the Turkish pharmaceutical industry.
Ulkar Holding and Nobel Pharmaceuticals Head Office moved from Besiktaş to their new head office in Ümraniye.
Nobel Pharmaceuticals representation offices were opened in Ukraine, Albania and Romania.
Nobel Pharmaceuticals representation offices were opened in Georgia, Moldova, Serbia and Russia.
Plantafarma was renamed to Nobelfarma.
The first finished product export was made to the EU (Germany)
Nobel Medicus began its publishing life.
Nobel Pharmaceuticals representation offices were opened in Azerbaijan, Bosnia and Herzegovina, Bulgaria, and Kyrgyzstan.
The first foreign manufacturing facility was established in Kazakhstan under the name of Nobel AFF.
Generinobel was founded in Germany.
FARGEM, the first R&D center in its field, was established within Düzce facilities.
Nobel Pharmsanoat was founded in Uzbekistan.
Plantafarma company in Düzce was acquired as the manufacturing facility.
Tylol Hot was approved, its brand and image were registered.
Manufacturing of active pharmaceutical ingredients was initiated by Ulkar Kimya.
Nobel Pharmaceuticals and other companies merged under the umbrella of Ulkar Holding.
Nobel Pharmaceuticals moved to its head office building in Beşiktaş.
